首站-论文投稿智能助手
期刊详情
《中国病毒学》
本刊由中国科学院武汉病毒研究所、中国微生物学会共同主办、科学出版社出版的学术性双月刊,创刊于1986年,原名为《病毒学杂志》(Virologica Sinica),季刊。1991年更名为《中国病毒学》,外文刊名不变,2003年改为双月刊,自创刊以来,发表病毒学研究论文1000多篇,发表论文基金率为65%以上。曾三次荣获湖北省优秀期刊奖,被评为中国生物学核心期刊、基础医学类核心期刊和中国科学引文数据库核心期刊。长期被BA(生物学文摘)、CA(化学文摘)和中国生物学文摘、医学文摘、农业学文摘等国内外20余种文摘及检索刊物收录,为国家科技部信息所“万方数据(ChinaInfo)系统”、清华大学“中国学术期刊光盘版”和“中国期刊网”的期刊源。是CSCI (中国科学引文索引)、中国生物学和医学期刊的核心期刊。影响因子为0.553 (2003年统计数据)
{{ isqkjj == false ? "展开" : "收起" }}
出版周期:双月刊
语种:英文
影响因子:0.83
国内刊号:42-1706/Q
国际刊号:1674-0769
♦ 主要栏目:研究报告 简报 综述
♦ 获奖情况:1990年湖北省期刊印刷质量奖,1994年-1995年度湖北省优秀期刊,湖北省第一届、第二届、第四届优秀期刊奖
♦ 收录情况: {{ e.split(":")[0] }} < 查看更新情况
♦ 期刊情况:CSCD,CSTPCD,SCI
♦ 主管单位:中国科学院
♦ 主办单位:中国科学院武汉病毒研究所,中国微生物学会
联系方式
主编:陈新文
电话:027-87199157
邮编:430071
邮箱:info@virosin.org
地址:武汉武昌区小洪山中区44号
发文分析
发文类型:
{{ obj.kz7 == 1 ? "学术" : obj.kz7 == 2 ? "学术+科普" : obj.kz7 == 3 ? "科普" : "未知" }}
年刊文量:
{{ obj.wznum }}篇
单期页码:
{{ obj.maxpage }}页
发文地域:
{{ item.name }}({{ (item.bl * 100).toFixed(2) }}%)
机构特征:
{{ item.word }}
发文热门词:
{{ item.name }}
文章分类:
{{ item.key }}({{ (item.value * 100).toFixed(2) }}%)
{{ iswzfl == false ? "展开更多" : "收起全部" }}
{{ item.flname }}[{{ item.name }}]({{ (item.bl * 100).toFixed(2) }}%)
A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis
An-Kai Zhu;Sa-Sa Li;Shu-Pei Yu;Zhao-Yong Zhang;Huan Li;Jing-Feng Li;Shan-Shan Gao;Heng Chen;Jincun Zhao;Run Shi;Mingjian Lu;Chaoyang Li - Affiliated Cancer Hospital and Institute of Guangzhou Medical University,State Key Laboratory of Respiratory Disease,Key Laboratory for Cell Homeostasis and Cancer Research of Guangdong High Education Institute,Guangzhou,510095,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,510182,China;Department of Interventional Radiology,Affiliated Cancer Hospital and Institute of Guangzhou Medical University,Guangzhou,510095,China
Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants
Xiaorui Xing;Lei Wang;Zhen Cui;Wangjun Fu;Tao Zheng;Lili Qin;Pingju Ge;Aidong Qian;Nan Wang;Shuai Yuan - College of Veterinary Medicine,Jilin Agricultural University,Changchun,130118,China;College of Animal Science and Technology,Jilin Provincial Engineering Research Center of Animal Probiotics,Key Lab of Animal Production,Product Quality and Security,Joint Laboratory of Modern Agricultural Technology International Cooperation,Ministry of Education,Jilin Agricultural University,Changchun,130118,China;CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100101,China;Acrobiosystems,Beijing,100101,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China
SARS-CoV-2 infection induces testicular injury in Rhesus macaque
Mengying Liang;Wanbo Tai;Yunyun Wang;Yulong Dai;Yanfeng Yao;Juan Min;Yiwu Zhou;Liang Liu;Chao Shan;Han Xia;Zhiming Yuan - Key Laboratory of Special Pathogens and Biosafety,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518069,China;Department of Forensic Medicine,Tongji Medical College of Huazhong University of Science and Technology,Wuhan,430030,China;Wuhan National Biosafety Laboratory,Chinese Academy of Sciences,Wuhan,430073,China;The Core Facility and Technical Support,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061 China
Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-KB positive feedback loop
Shuyu Xin;Lingzhi Liu;Yanling Li;Jing Yang;Lielian Zuo;Pengfei Cao;Qijia Yan;Shen Li;Li Yang;Taimei Cui;Jianhong Lu - Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,410013,China;Department of Microbiology,School of Basic Medical Science,Central South University,Changsha,410078,China;The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education,NHC Key Laboratory of Carcinogenesis,Cancer Research Institute,Central South University,Changsha 410078,China;China-Africa Research Center of Infectious Diseases,Central South University,Changsha,410013,China;Department of Hematology,National Clinical Research Center for Geriatric Disorders,Department of Pathology,Xiangya Hospital,Central South University,Changsha,410080,China
Clinical characteristics and molecular epidemiology of human metapneumovirus in children with acute lower respiratory tract infections in China,2017 to 2019:A multicentre prospective observational study
Hongwei Zhao;Qianyu Feng;Ziheng Feng;Yun Zhu;Junhong Ai;Baoping Xu;Li Deng;Yun Sun;Changchong Li;Rong Jin;Yunxiao Shang;Xiangpeng Chen;Lili Xu;Zhengde Xie - Beijing Key Laboratory of Pediatric Respiratory Infection Diseases,Key Laboratory of Major Diseases in Children,Ministry of Education,National Clinical Research Center for Respiratory Diseases,National Key Discipline of Pediatrics(Capital Medical University),Beijing Pediatric Research Institute,Beijing Children's Hospital,Capital Medical University,National Center for Children's Health,Beijing 100045,China;Research Unit of Critical Infection in Children,Chinese Academy of Medical Sciences,2019RU016,China;Department of Respiratory Diseases I,Beijing Children's Hospital,Capital Medical University,National Clinical Research Center for Respiratory Diseases,National Center for Children's Health,Beijing,100045,China;Guangzhou Women and Children's Medical Center,Guangzhou,510623,China;Yinchuan Maternal and Child Health Hospital,Yinchuan,750000,China;The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,325027,China;Guiyang Women and Children Healthcare Hospital,Guiyang,550003,China;Shengjing Hospital of China Medical University,Shenyang 110004,China
Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant:A single-center study in China
Mengyuan Chen;Jiaqin Xu;Lingjun Ying;Miaoguo Cai;Tao-Hsin Tung;Kai Zhou;Yufen Zheng;Xiaojie Bi;Jing Wang;Xi Tu;Bo Shen;Dongqing Lv - Department of Laboratory Medicine,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Hepatology and Infectious Diseases Center,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Department of Radiation Oncology,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Evidence-based Medicine Center,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China;Department of Respiratory and Critical Diseases,Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University,Taizhou,317000,China
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
Yuqi Zhu;Xinyi Yang;Jingna Xun;Jun Liu;Qing Wen;Yixiao Lin;Xiaoting Shen;Jun Chen;Songhua Yuan;Xiaying Zhao;Jing Wang;Hanyu Pan;Jinlong Yang;Zhiming Liang;Yue Liang;Qinru Lin;Huitong Liang;Min Li;Jianping Liu;Yinzhong Shen;Xiaoyan Zhang;Pengfei Wang;Daru Lu;Chunhua Yin;Jianqing Xu;Shibo Jiang;Hongzhou Lu;Huanzhang Zhu - State Key Laboratory of Genetic Engineering and Engineering Research Center of Gene Technology,Ministry of Education,Institute of Genetics,School of Life Sciences,Fudan University,Shanghai,200438,China;Scientific Research Center,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Fubio(Suzhou)Biomedical Technology Co.,Ltd,Suzou,215300,China;Department of Infectious Diseases and Immunology,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences,Fudan University,Shanghai,200032,China;Department of Infectious Diseases and Nursing Research Institution,National Clinical Research Center for Infectious Diseases,The Third People's Hospital of Shenzhen,Shenzhen,518112,China
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
Xiao-Li Feng;Dandan Yu;Mi Zhang;Xiaohong Li;Qing-Cui Zou;Wentai Ma;Jian-Bao Han;Ling Xu;Cuixian Yang;Wang Qu;Zhong-Hua Deng;Junyi Long;Yanghaopeng Long;Mingkun Li;Yong-Gang Yao;Xing-Qi Dong;Jianxiong Zeng;Ming-Hua Li - Kunming National High-level Biosafety Research Center for Non-Human Primates,Center for Biosafety Mega-Science,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650107,China;Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences,and KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China;National Resource Center for Non-Human Primates,National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility),Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming 650107,China;Department of Infectious Diseases,Yunnan Provincial Infectious Diseases Hospital,Kunming,650301,China;Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,and China National Center for Bioinformation,Beijing,100101,China;University of Chinese Academy of Sciences,Beijing,100049,China;Center for Excellence in Animal Evolution and Genetics,Chinese Academy of Sciences,Kunming,650201,China;Kunming College of Life Science,University of Chinese Academy of Sciences,Kunming 650204,China;Yunnan Key Laboratory of Biodiversity Information,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China
学者H指数区间
机构H指数区间

1、投稿方式:在线投稿。

2、刊内网址:http://www.virosin.org/

在线系统:

http://mc03.manuscriptcentral.com/vs

3、刊内邮箱:zhengli.shi@virosin.org(主编)

virologica@wh.iov.cn(编辑部)

更多官网编辑邮箱如下。

4、刊内电话:027-87199157

官网电话:027-87199121

5、出刊日期:双月刊,逢双月出版。

2021511日星期二

                                  

 

《中国病毒学(英文)》编辑邮箱

【官网信息】

 

Contacts Us

Editor-in-Chief  Zheng-Li Shi, Ph.D

Professor, Wuhan Institue of Virology, Chinese Academy of Sciences

zhengli.shi@virosin.org

Director of Editorial Office,

Executive Editor

Jiali Si, Ph.D, editorial@virosin.org

Scientific Editors   Dongbo Nie, virosin@wh.iov.cn

Wei Pan, virologica@wh.iov.cn

Production Editor    Jinglin Zhang, production@virosin.org

Editorial Office Wuhan Institute of Virology, Chinese Academy of Sciences

No.44, Xiao Hong Shan, Wuhan 430071, China

Phone:+86-27-87199157,+86-27-87199121

Fax:+86-27-87199157

 

《中国病毒学(英文)投稿须知

202006信息】

 

INSTRUCTIONS FOR AUTHORS

TYPES OF ARTICLES

1. Research articles

Research articles belong to the full length article type, and should include elements as follows: title, running title, and byline; correspondent footnote; abstract and keywords; introduction; materials and methods; results; discussion; acknowledgements; compliance; author contributions; references; figure legends and figures/tables. The article length generally should not exceed 6,000 words, and detailed requirements are in the Format section.

2. Review articles

Review articles are summaries of important developments in virology research. They must be based on published articles and may address any subject within the scope of the journal. Reviews must have abstracts and keywords, and the body may have section headings and/ or paragraph lead-ins. The article length can be 4,000 words and more.

3. Letters

Letters are intended for the presentation of brief observations and published in a short-form format. The text should not exceed 1,500 words (exclusive of references); the number of figures and tables should be kept into one, while references are limited to 15.

4. Commentaries

Articles of commentaries are communications concerning topics relevant to the readership of Virologica Sinica and may include Editorials, Perspectives, News & Views, Meeting reports and Recollections. The article length may vary depending on article types.

FORMATS OF ARTICLES

The manuscript should be double-spaced throughout using 15px Times New Roman. Number all pages. Research articles should begin with section of title page, and followed by abstract, keywords, introduction, materials and methods, results, discussion, acknowledgements, compliance, author contributions, references, figure legends and figures/ tables. Gene symbols and virus species should be italicized; protein products are not italicized. Non-standard abbreviations should be defined when first used in the text.

1. Title page:

The title page should include: Full title (a brief declarative statement of the major findings of the research), Running title (no more than 60 characters including spaces), each author’s affiliation and corresponding author’s contact information (Phone, Fax and Email).

2. Abstract:

The abstract should briefly (no more than 250 words) describe in complete sentences the scope of the investigation, the results obtained and the major conclusions, and 3-7 keywords should be given after the abstract. There is no Abstract, no sections on Introduction, Methods, Results or Discussion in “Letter type” publications.

3. Introduction:

The introduction should begin with a brief introduction of the background related to the research and should be as concise as possible.

4. Materials and Methods:

The materials and methods should be described clearly and referenced in sufficient detail. For commonly used materials and methods (e.g., media and protein concentration determinations), a simple reference is sufficient.

5. Results:

The results should present the experimental data in tables and figures with suitable descriptions. Present the results as concisely as possible in one of the following: text, table(s), or figure(s). Number figures and tables in numerical order like 1, 2, 3, etc., and be sure to cite all figures and tables.

6. Discussion:

The discussion should focus on the interpretation and significance of the findings with concise objective comments. It should not contain extensive repetition of the Results section or reiteration of the introduction.

7. Acknowledgments:

The acknowledgements should include people who contributed to the work but do not fit the criteria for authors and financial supports along with the numbers of grants.

8. Compliance:

In order to comply with the ethical requirements of the journal, the following statements must be included in a separate section entitled Compliance with Ethics Guidelines”. For studies with animal subjects, please include: All institutional and national guidelines for the care and use of laboratory animals were followed.

For studies with human subjects, please include:

Additional informed consent was obtained from all patients for which identifying information is included in this article.

For articles do not contain any human or animal studies, please include:

This article does not contain any studies with human or animal subjects performed by any of the authors.

Besides, the author(s) should declare whether he (she) has competing interest in this section.

9. Author contributions:

According to ICMJE guidelines, authorship should be based on the following four criteria: 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and 2) Drafting the work or revising it critically for important intellectual content; and 3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Other contributors who do not meet the four criteria for authorship should be listed in the acknowledgements section.

10. References:

The citations for Virologica Sinica in the article body are adhered to author-year system.

Reference list are ordered alphabetically as the first author’s family name. References listed in the References section should include only publications that are published or in press. PhD thesis cannot be cited as references. The Endnote style of Virologica Sinica can be downloaded from www.virosin.org, or send to you via email upon request.

An example of reference style:

Tian YJ, Ou JH (2015) Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma. Virol Sin 30:85–91.

The reference information appears as (Tian et al, 2015) in the article body.

11. Illustrations and tables

Figures and images should be labeled sequentially, numbered and cited in the text. Figures should be submitted separately, and referred in the text of the paper. Acceptable formats for figures are: TIFF, AI, EPS, PSD and JPEG. Pixel requirements are:

a) 300 dpi for grayscale and color; b) 600 dpi for combination art (lettering and images); c) 1,200 dpi for line art.

Figure legends should appear on a separate manuscript page after the Reference section, with a title of “Titles and legends to figures”.

Detailed experimental methods should not appear in figure legends.

Define all symbols used in the figure and define all abbreviations that are not used in the text. Use scale markers in the image for electron micrographs, and indicate the type of stain used. Line chart should express the data clearly and precisely. X and Y axises should be accurately and briefly marked and error bar should be provided if necessary.

The accepted format for regular tables is Microsoft Word/Excel. Each table should be typed at the end of the references, numbered and titled, and cited in the text. The headings should be sufficiently clear, and explanatory footnotes for abbreviations are necessary.

Please do not submit copyrighted figures or tables. If so, authors are responsible for acquiring reuse permission.

12. Nomenclature and abbreviations

Names used for viruses should be those approved by the International Committee on Taxonomy of Viruses (ICTV) and reported on the ICTV Virus Taxonomy website. In addition, the standard usage of virus specie names should follow recommendations of the ICTV: when the entire species is discussed as a taxonomic entity, the species name, as with other taxa, is italic and has the first letter and any proper nouns capitalized (e.g., Tobacco mosaic virus). When the behavior or manipulation of individual viruses is discussed, the vernacular (e.g., tobacco mosaic virus) should be used. Genes, mutations, genotypes, and alleles should be italicized while proteins should be set in roman type. The virus name and abbreviations not so conventional (like PCR, DNA, ATP) must be written out in full, both in the title of the manuscript and at the first mention in the manuscript; after that, abbreviations mentioned may be used.

HOW TO SUBMIT A MANUSCRIPT

Authors are encouraged to submit their manuscripts via online submission at http://mc03.manuscriptcentral.com/vs. Files should be uploaded individually, and are automatically combined into a single PDF file by the submission system. The original submission should be deleted when submitting a revision because the original one has been automatically saved in the system.

If you have problems with the online submission, please contact editorial office at virologica@wh.iov.cn. Phone: 86-27-87199157.


学术论文:{{ zhichengxiangqing.pkmark || 0 }}篇
科普文章:{{ zhichengxiangqing.hxmark || 0 }}篇
职称要求查看来源
职称说明
以上信息,由域田数据科技根据网络公开资料自动分析生成,仅供参考!